REBECCA HAGENSEE: Open Payments
NPI 1992089890 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 39 payments from 12 companies in 2025. Trend: 2023 $436 · 2024 $750 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $367 |
| CVRx, Inc. | 2 | $200 |
| SCPHARMACEUTICALS INC. | 3 | $182 |
| Novartis Pharmaceuticals Corporation | 6 | $149 |
| Amgen Inc. | 5 | $92 |
| PFIZER INC. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $44 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, FUROSCIX, LEQVIO, REPATHA, CARDIOMEMS, CAMZYOS, VYNDAQEL.
Industry payments across IL — which companies pay providers there.
